Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nikolaus

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|May 14, 1999
Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptorS Nikolaus, J P Huston, R U Hasenöhrl
Neuroreport|August 10, 1999
The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injectionS Nikolaus, J P Huston, R U Hasenöhrl
Alimentary Pharmacology & Therapeutics|September 9, 2004
Review article: exploration of the genetic aetiology of inflammatory bowel disease--implications for diagnosis and therapyS Schreiber, J Hanpe, S Nikolaus, et al.
Nuklearmedizin. Nuclear Medicine|December 8, 2015
Pharmacological treatment with L-DOPA may reduce striatal dopamine transporter binding in in vivo imaging studiesS Nikolaus, C Antke, H Hautzel, et al.
Behavioral and Neural Biology|September 1, 1994
Chronic administration of neurokinin SP improves maze performance in aged Rattus norvegicusR U Hasenöhrl, C Frisch, S Nikolaus, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 28, 2008
Entrance effects at nanopores of nanocapsules functionalized with poly(ethylene glycol) and their flow through nanochannelsRaluca Popa, M Vrânceanu, S Nikolaus, et al.
Molecular Psychiatry|May 28, 2005
In vivo snapshots of the dopaminergic synapse in small animalsS Nikolaus, M Beu, A Wirrwar, et al.
Nuklearmedizin. Nuclear Medicine|January 10, 2006
[State-of-the-art of small animal imaging with high-resolution SPECT]S Nikolaus, A Wirrwar, C Antke, et al.
Peptides|January 1, 1997
Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesionS Nikolaus, J P Huston, B Körber, et al.
Nuclear Medicine Communications|February 24, 2001
Diffuse cortical reduction of neuronal activity in unipolar major depression: a retrospective analysis of 337 patients and 321 controlsS Nikolaus, R Larisch, M Beu, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|May 14, 1999
Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptorS Nikolaus, J P Huston, R U Hasenöhrl
Neuroreport|August 10, 1999
The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injectionS Nikolaus, J P Huston, R U Hasenöhrl
Alimentary Pharmacology & Therapeutics|September 9, 2004
Review article: exploration of the genetic aetiology of inflammatory bowel disease--implications for diagnosis and therapyS Schreiber, J Hanpe, S Nikolaus, et al.
Nuklearmedizin. Nuclear Medicine|December 8, 2015
Pharmacological treatment with L-DOPA may reduce striatal dopamine transporter binding in in vivo imaging studiesS Nikolaus, C Antke, H Hautzel, et al.
Behavioral and Neural Biology|September 1, 1994
Chronic administration of neurokinin SP improves maze performance in aged Rattus norvegicusR U Hasenöhrl, C Frisch, S Nikolaus, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 28, 2008
Entrance effects at nanopores of nanocapsules functionalized with poly(ethylene glycol) and their flow through nanochannelsRaluca Popa, M Vrânceanu, S Nikolaus, et al.
Molecular Psychiatry|May 28, 2005
In vivo snapshots of the dopaminergic synapse in small animalsS Nikolaus, M Beu, A Wirrwar, et al.
Nuklearmedizin. Nuclear Medicine|January 10, 2006
[State-of-the-art of small animal imaging with high-resolution SPECT]S Nikolaus, A Wirrwar, C Antke, et al.
Peptides|January 1, 1997
Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesionS Nikolaus, J P Huston, B Körber, et al.
Nuclear Medicine Communications|February 24, 2001
Diffuse cortical reduction of neuronal activity in unipolar major depression: a retrospective analysis of 337 patients and 321 controlsS Nikolaus, R Larisch, M Beu, et al.
Pageof 6